Graphic: Vioxx Legal Resources.com
Offices

Image: Gavel and Law Books
Attorney Advertising Disclaimer


Graphic: Summary tab
Vioxx Recall: The international prescription drug company Merck announced in September 2004 the worldwide withdrawal of the arthritis medication Rofecoxib, sold in most countries under the brand name Vioxx, because a study showed an increased risk of heart attack and stroke.

Vioxx Trial: Patients who have suffered injuries due to Vioxx have filed litigation against Merck for selling Vioxx even though Merck allegedly was aware of Vioxx's dangerous side effects.


 


Vioxx Heart Attack Risk & Personal Injury Lawyers - Press Articles

2007-2008 | 2006 | 2005 | 2004
2003
| 2002 | 2001 | Timeline
Below are summaries of press articles on the Vioxx trials and Vioxx class action. For a concise review of the Vioxx recall and how patients with Vioxx side effects may file a Vioxx lawsuit and obtain compensation, please visit our main page.
 
April 17, 2008
International Herald-Tribune, "Merck wrote drug studies for doctors"
Merck drafted dozens of research studies for a best-selling drug, then lined up prestigious doctors to put their names on the reports before publication. More...
 
November 9, 2007
San Francisco Chronicle, "Merck to Pay $4.85B Vioxx Settlement"
Merck & Co. said Friday it will pay $4.85 billion to end thousands of state and federal lawsuits over its painkiller Vioxx in one of the largest drug settlements ever. Company officials estimated the deal, if accepted, would end 45,000 to 50,000 personal injury lawsuits involving U.S. Vioxx users who suffered a heart attack or ischemic stroke, the type in which blood flow to the brain is blocked. More...
 
November 9, 2007
New York Times, "Merck Agrees to Pay $4.85 Billion for Vioxx Claims"
Three years after withdrawing its pain medication Vioxx from the market, Merck announced today that it will pay $4.85 billion to settle 27,000 lawsuits by people who contend they or their family members suffered injury or died after taking the drug. More...
 
March 13, 2007
First Coast News, "Vioxx Jury Awards $47.5M to Idaho Couple"
          Merck & Co.'s painkiller Vioxx contributed to an Idaho postal worker's heart attack, a jury in Atlantic City ruled Monday, reversing the verdict in the man's first trial and hitting Merck with a total of $47.5 million in damages. In one of Merck's biggest losses over the drug so far, the jurors awarded the man and his wife $20 million in compensatory damages Monday morning, then later said Merck should pay $27.5 million in punitive damages. More...

Lieff Cabraser: Experienced Product Liability Lawyers
Founded in 1972, Lieff Cabraser Heimann & Bernstein, LLP is an over fifty attorney law firm with offices in San Francisco, New York and Nashville. For the last five years, the National Law Journal has recognized Lieff Cabraser as one of the top plaintiffs’ law firms in America.
For our personal injury cases, we bring a team of experienced lawyers. Each client is assigned a partner and an associate. In addition, we have on staff multiple nurses, legal assistants, scientific analysts and case clerks to assist the attorneys.
We have represented thousands of patients who ingested prescription drugs with dangerous undisclosed side effects, and patients who received defective medical devices in personal injury lawsuits across America, including residents of Alaska, Alabama, Arkansas, Arizona, California, Colorado, Connecticut, Delaware, Florida, Georgia, Hawaii, Idaho, Illinois, Indiana, Kansas, Kentucky, Louisiana, Massachusetts, Maryland, Maine, Michigan, Minnesota, Missouri, Montana, North Carolina, North Dakota, Nebraska, New Hampshire, New Jersey, New Mexico, Nevada, New York, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Dakota, Tennessee, Texas, Utah, Virginia, Vermont, Washington, Wisconsin, West Virginia and Wyoming.

Images: Supreme Court, Law Books, Scales and pill images
Lieff Cabraser Heimann & Bernstein, LLP

Trademark Notice
"Vioxx" is a registered trademark of Merck. Lieff Cabraser Heimann & Bernstein, LLP is in no way affiliated with Merck, and the Vioxx trademark is used solely for informational purposes.

Copyright © 2007 Lieff Cabraser Heimann & Bernstein, LLP

Graphic: Latest News
Merck Agrees to Resolve U.S. VIOXX® Product Liability Lawsuits
November 9, 2007
 
Merck & Co., Inc. announced that it has entered into an agreement to resolve state and federal myocardial infarction (MI) and ischemic stroke claims already filed against the Company in the United States. More...


Graphic: Verdicts & Settlements header


Graphic: Press Articles


Graphic: Timeline